7. The effectiveness of mifepristone combined with misoprostol onabortion of from 13 to 22 weeks of gestation at the National hospital of obstetrics and gynecology
Main Article Content
Abstract
Regimen of the second-trimester abortion following National Manual Handbook, published in 2016, has not been researched. Our objective isto evaluate the effect of Mifepristone and Misoprostol on the second-trimeter abortion between 2 groups of 13 - 18 weeks and 19 - 22 weeks gestation. Methodology: this is a cross-sectional descriptive study at the National Hospital of Obstetrics and Gynecology among 130 gravidas with gestational age from 13 to 22 weeks, who underwent a medical abortion. Results: The miscarriage rate is 99.23%, the miscarriage time is 7.7 ± 3.67 (hours), and the smaller the fetal age – the shorter the miscarriage time and the lower the dosage . The rate of uterine intervention after the natural third stage of labour is 16.28%, the most frequent complication is fever (26.15%). Conclusion: The combination of Mifepristone and Misoprostol is highly effective for medical abortion during the secondtrimeter.
Article Details
Keywords
Abortion, Mifepristone and Misoprostol, second-trimester abortion
References
2. Safe abortion: technical and policy guidance for health systems. Reproductive Health Matters. 2012; 20(39): 205-207. doi:10.1016/S0968-8080(12)39623-7.
3. Grossman D, Blanchard K, Blumenthal P. Complications after Second Trimester Surgical and Medical Abortion. Reproductive Health Matters. 2008; 16(sup31): 173-182. doi:10.1016/S0968-8080(08)31379-2.
4. Abortion care guideline. Accessed February 24, 2023. https://www.who.int/publications/i/item/9789240039483.
5. Vũ Văn Khanh. Nghiên cứu hiệu quả và tính an toàn khi sử dụng Mifepristone phối hợp với Misoprostol để kết thúc thai nghén cho thai từ 10 đến 20 tuần tuổi tại Bệnh viện Phụ sản Trung ương. Luận văn tiến sỹ Y học. Trường đại học Y Hà Nội; 2016.
6. Nguyễn Thị Lan Hương. Nghiên cứu hiệu quả phá thai từ 13 đến 22 tuần của Misoprostol đơn thuần và Mifepristone kết hợp Misoprostol. Luận văn tiến sỹ Y học. Trường đại học Y Hà Nội; 2012.
7. Louie KS, Chong E, Tsereteli T, et al. Second trimester medical abortion with mifepristone followed by unlimited dosing of buccal misoprostol in Armenia. The European Journal of Contraception & Reproductive Health Care. 2017; 22(1): 76-80. doi:10.1080/13625187.2016.1258461.
8. Bebbington MW, Kent N, Lim K, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. American Journal of Obstetrics and Gynecology. 2002; 187(4): 853-857. doi:10.1067/mob.2002.127461.
9. Ramsey PS, Savage K, Lincoln T, et al. Vaginal Misoprostol Versus Concentrated Oxytocin and Vaginal PGE2 for Second-Trimester Labor Induction. Obstetrics & Gynecology. 2004; 104(1): 138. doi:10.1097/01.AOG.0000128947.31887.94.
10. Nilas L, Glavind-Kristensen M, Vejborg T, et al. One or two day mifepristone–misoprostol interval for second trimester abortion. Acta Obstetricia et Gynecologica Scandinavica. 2007; 86(9): 1117-1121. doi:10.1080/00016340701505002.
11. Nautiyal D, Mukherjee K, Perhar I, et al. Comparative Study of Misoprostol in First and Second Trimester Abortions by Oral, Sublingual, and Vaginal Routes. J Obstet Gynecol India. 2015; 65(4): 246-250. doi:10.1007/s13224-014-0587-3.
12. Hamoda H, Ashok PW, Flett GMM, et al. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation. Human Reproduction. 2005; 20(8): 2348-2354. doi:10.1093/humrep/dei037.
13. Ngoc NTN, Shochet T, Raghavan S, et al. Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-Trimester Abortion: A Randomized Controlled Trial. Obstetrics & Gynecology. 2011; 118(3): 601. doi:10.1097/AOG.0b013e318227214e.